sufentanil has been researched along with propranolol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (46.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, PR; Craik, DJ; Martin, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kampine, JP; Schmeling, WT; Warltier, DC | 1 |
| Cicero, TJ; Miller, BT | 1 |
| Ahn, NC; Berthelsen, P; Eriksen, J; Rasmussen, JP | 2 |
| Berthelsen, P; Eriksen, J; Rasmussen, JP; Strøm, J | 1 |
| Boscoe, MJ; de Bruijn, N; de Lange, S; Stanley, TH | 1 |
| Barişkaner, H; Doğan, N; Kiliç, M; Otelcioğlu, S; Tuncer, S; Yosunkaya, A | 1 |
1 review(s) available for sufentanil and propranolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
14 other study(ies) available for sufentanil and propranolol
| Article | Year |
|---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Negative chronotropic actions of sufentanil and vecuronium in chronically instrumented dogs pretreated with propranolol and/or diltiazem.
Topics: Analgesics; Animals; Diltiazem; Dogs; Drug Interactions; Electrocardiography; Fentanyl; Heart Rate; Hemodynamics; Naloxone; Propranolol; Sufentanil; Vecuronium Bromide | 1989 |
Ascorbate-induced release of LHRH: noradrenergic and opioid modulation.
Topics: Animals; Ascorbic Acid; Calcium; Fentanyl; Gonadotropin-Releasing Hormone; Hypothalamus, Middle; In Vitro Techniques; Male; Phentolamine; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic; Receptors, Opioid; Sufentanil | 1987 |
Skeletal muscle circulation during sufentanyl and morphine anesthesia in propranolol treated dogs.
Topics: Adrenergic beta-Antagonists; Analgesics, Opioid; Animals; Blood Volume; Dogs; Dose-Response Relationship, Drug; Fentanyl; Hematocrit; Hydrogen-Ion Concentration; Morphine; Muscles; Propranolol; Regional Blood Flow; Sufentanil; Vascular Resistance | 1981 |
High-dose analgesic anesthesia with morphine or sufentanil in propranolol-treated dogs.
Topics: Analgesics, Opioid; Anesthesia; Animals; Carbon Dioxide; Dogs; Fentanyl; Hemodynamics; Hydrogen-Ion Concentration; Morphine; Oxygen Consumption; Propranolol; Sufentanil; Time Factors | 1981 |
The influence of chronic preoperative propranolol therapy on cardiovascular dynamics and narcotic requirements during operation in patients with coronary artery disease.
Topics: Anesthesia, General; Coronary Artery Bypass; Coronary Disease; Fentanyl; Hemodynamics; Humans; Middle Aged; Narcotics; Nitroprusside; Nitrous Oxide; Phentolamine; Propranolol; Sufentanil | 1982 |
Peripheral circulation during sufentanyl and morphine anesthesia.
Topics: Anesthesia, Intravenous; Animals; Blood Circulation; Dogs; Fentanyl; Hematocrit; Hydrogen-Ion Concentration; Microcirculation; Morphine; Muscles; Propranolol; Sufentanil; Vascular Resistance | 1980 |
[The effects of sufentanil and remifentanil in the isolated perfused rat kidney].
Topics: Analgesics, Opioid; Animals; Glyburide; Indomethacin; Kidney; Male; Piperidines; Propranolol; Rats; Rats, Wistar; Remifentanil; Sufentanil; Tetraethylammonium | 2004 |